Supportan N/A is a Product of the Generic EPA + DHA + High Protein
Supportan N/A belongs to the generic category of EPA + DHA + High Protein. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Supportan N/A. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand EPA + DHA + High Protein and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.
*Up to 10% Discount
(Depends on pharmacy)
Supportan N/A
Radiant Pharmaceuticals Ltd. (Mfg. by: Fresenius Kabi) · Solution
EPA + DHA + High Protein
/ 200 ml bottle (Tropical Fruits)
Description of Supportan N/A
Supportan N/A may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Supportan N/A is provided below to help users gain a clear understanding of this medicine.
What Is Supportan Indications and Uses?
Food for special medical purposes: For the dietary management in case/risk of malnutrition, esp. with cancer, chronic catabolic diseases and/or cachexia. Nutritionally complete, high energy (1,5 kcal/ml), high protein oral nutritional supplement with fibre. High in EPA and DHA from fish oil, high in fat, with MCT. Clinically free from lactose, gluten free.
Dosage And Administration of Supportan
2 bottles/day for supplementary nutrition or ≥5 bottles/day for complete nutrition, or as advised by a healthcare professional.To be used under medical supervision. Suitable as sole source of nutrition. If used for complete nutrition consider high fish oil levels. Not suitable for children <3 years. Use with caution in children < 6 years. Not suitable in case of galactosaemia.Best served chilled. Shake well before use. Packaged in a protective atmosphere.
Storage Conditions of It
At room temperature. Once opened refrigerate and use within 24 hours.
Data Source: Data source of Indications and Usages, Pharmacology, Dosage & Administration, Drug Interactions, Side Effects, Use during Pregnancy & Lactation, Precautions & Warnings, Use in Special Populations, Therapeutic Class, and Storage Conditions is the concerned medicine company or respective organization.
Alternative Medicines
⚠ Disclaimer
The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines
N:B-All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines"
Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved
DBID
Registration ID: 176322642
Trade License: TRAD/DNCC/040904/2023
